| Document Date: 2014-08-29 01:06:35
Open Document File Size: 346,57 KBShare Result on Facebook
Company Ames / / Facility A01-1107 Laboratory / / IndustryTerm chemical name / treatment of advanced breast cancer / / MedicalCondition IV non-small cell lung cancer / Severe irritation / thrombophlebitis / interstitial pneumonitis / measurable disease / bronchospasm / cancer / disease / NSCLC / yellow fever / II disease / severe hepatic injury / Neutropenia / Mitomycin - Acute pulmonary reactions / alopecia / ischaemic heart disease / Known hypersensitivity / fever / polio / severe bronchospasm / vomiting / severe infection / ischaemic cardiac disease / CLINICAL TRIALS Advanced breast cancer / pre-existing pulmonary dysfunction / diseases / non-small cell lung cancer / advanced non-small cell lung cancer / anthracyclinerefractory advanced breast cancer / severe liver disease / granulocytopenia / infection / less nausea / pulmonary tissue / generalised vaccine disease / extravasation causing local tissue necrosis / depression / advanced breast cancer / irreversible infertility / cholestasis / tumoral diseases / hepatic insufficiency / severe neutropenia / fatal generalised vaccine disease / / MedicalTreatment contraception / anticancer therapy / chemotherapy / radiotherapy / / Organization World Health Organization / Intrathecal administration / DOSAGE AND ADMINISTRATION / Improper administration / A01-1107 Laboratory / / Position physician / / Product carboplatin / Phenytoin / cisplatin / Itraconazole / paclitaxel / NAVELBINE / ketoconazole / ifosfamide / fluorouracil / vinorelbine tartrate / mitoxantrone / mitomycin / / Technology Pharmacokinetics / chemotherapy / /
SocialTag |
PRODUCT INFORMATION NAVELBINE® Injection 10 mg/mL, 40 mg/4 mL, 50 mg/5 mL NAME OF THE DRUG vinorelbine tartrate